Francisella

(redirected from Francisella tularensis)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to Francisella tularensis: Pasteurella multocida

Francisella

[‚fran·si′sel·ə]
(microbiology)
A genus of gram-negative, aerobic bacteria of uncertain affiliation; cells are small, coccoid to ellipsoidal, pleomorphic rods and can be parasitic on mammals, birds, and arthropods.
Mentioned in ?
References in periodicals archive ?
Since then, several organisms causing SENLAT have been described, namely, Rickettsia slovaca, Rickettsia raoultii, and Francisella tularensis [17].
Metzger, "Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain," Infection and Immunity, vol.
Oyston, "A Francisella tularensis SCHU S4 mutant deficient in (gamma)-glutamyltransferase activity induces protective immunity: characterization of an attenuated vaccine candidate," Microbiology, vol.
Francisella tularensis (FT) is an intracellular gram negative high virulent bacterial which causes tularemia disease in human (Faron et al.
Virulence differences among Francisella tularensis subsp.
Fischer et al., "Francisella tularensis induces extensive caspase-3 activation and apoptotic cell death in the tissues of infected mice," Infection and Immunity, vol.
Affiliation to the species Francisella tularensis was confirmed by amplification of the 17 kDa outer membrane lipoprotein gene fragment (species-specific tul4 gene) as described previously [16].
Uklucie kleszcza nie powoduje tej choroby, poniewaz paleczki Francisella tularensis nie lokuja sie w jego gruczolach slinowych, czyli nie wystepuja w slinie bedacej zrodlem innych patogenow [37,38].
This report provides comprehensive information on the therapeutic development for Francisella Tularensis Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
The company added that TP-271 is its novel, broad spectrum antibiotic candidate that is being developed to combat respiratory disease caused by bacterial biothreats and antibiotic-resistant public health pathogens, including Francisella tularensis, Yersinia pestis and Bacillus anthracis, as well as bacterial pathogens associated with community-acquired bacterial pneumonia.
Both iNOS and Phox are IFNa inducible genes involved in the regulation of the immune response and intestinal pathology during infection with Francisella tularensis .
dubia is susceptible to infection by Francisella tularensis LVS strain and that several genetic deletion strains that are attenuated in mice are also attenuated in this assay.